Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 3/2013

01-03-2013 | Review

Is Helicobacter pylori good or bad?

Author: S. Mishra

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2013

Login to get access

Abstract

Helicobacter pylori remains a controversial organism with regards to humans, with its epidemiology still being unclear nearly two decades after its discovery. The association between H. pylori infection and subsequent development of chronic active gastritis, peptic ulcer disease, gastric cell carcinoma, and B cell mucosa-associated lymphoid tissue (MALT) lymphoma has been well established. Current studies, however, suggest that fewer than 20 % of all infected patients will develop any consequences from their infection. Hence, should the infection be considered a disease not at all or, on the contrary, is the microorganism harmful in only some circumstances? This article attempts to weigh the currently available evidence supporting that H. pylori may be good and not always bad.
Literature
1.
go back to reference Cover TL, Blaser MJ (2009) Helicobacter pylori in health and disease. Gastroenterology 136:1863–1873PubMedCrossRef Cover TL, Blaser MJ (2009) Helicobacter pylori in health and disease. Gastroenterology 136:1863–1873PubMedCrossRef
2.
go back to reference Hopkins RJ, Girardi LS, Turney EA (1996) Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 110:1244–1252PubMedCrossRef Hopkins RJ, Girardi LS, Turney EA (1996) Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 110:1244–1252PubMedCrossRef
3.
go back to reference Gerhard M, Lehn N, Neumayer N et al (1999) Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A 96(22):12778–12783PubMedCrossRef Gerhard M, Lehn N, Neumayer N et al (1999) Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A 96(22):12778–12783PubMedCrossRef
4.
go back to reference van Doorn LJ, Figueiredo C, Sanna R et al (1998) Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115(1):58–66PubMedCrossRef van Doorn LJ, Figueiredo C, Sanna R et al (1998) Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115(1):58–66PubMedCrossRef
5.
go back to reference Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R (1999) Helicobacter pylori virulence and genetic geography. Science 284:1328–1333PubMedCrossRef Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R (1999) Helicobacter pylori virulence and genetic geography. Science 284:1328–1333PubMedCrossRef
6.
go back to reference Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ (1985) Attempt to fulfil Koch’s postulates for pyloric Campylobacter. Med J Aust 142(8):436–439PubMed Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ (1985) Attempt to fulfil Koch’s postulates for pyloric Campylobacter. Med J Aust 142(8):436–439PubMed
7.
go back to reference Marshall BJ (1995) Helicobacter pylori in peptic ulcer: have Koch’s postulates been fulfilled? Ann Med 27(5):565–568PubMedCrossRef Marshall BJ (1995) Helicobacter pylori in peptic ulcer: have Koch’s postulates been fulfilled? Ann Med 27(5):565–568PubMedCrossRef
8.
go back to reference Blaser MJ (1999) Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 179:1523–1530PubMedCrossRef Blaser MJ (1999) Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 179:1523–1530PubMedCrossRef
9.
go back to reference Song Q, Lange T, Spahr A, Adler G, Bode G (2000) Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR. J Med Microbiol 49:349–353PubMed Song Q, Lange T, Spahr A, Adler G, Bode G (2000) Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR. J Med Microbiol 49:349–353PubMed
10.
go back to reference Monstein HJ, Tiveljung A, Kraft CH, Borch K, Jonasson J (2000) Profiling of bacterial flora in gastric biopsies from patients with Helicobacter pylori-associated gastritis and histologically normal control individuals by temperature gradient gel electrophoresis and 16S rDNA sequence analysis. J Med Microbiol 49:817–822PubMed Monstein HJ, Tiveljung A, Kraft CH, Borch K, Jonasson J (2000) Profiling of bacterial flora in gastric biopsies from patients with Helicobacter pylori-associated gastritis and histologically normal control individuals by temperature gradient gel electrophoresis and 16S rDNA sequence analysis. J Med Microbiol 49:817–822PubMed
11.
go back to reference Boulos PB, Botha A, Hobsley M, Holton J, Oshowo AO, Tovey FI (2002) Possible absence of Helicobacter pylori in the early stages of duodenal ulceration. QJM 95:749–752PubMedCrossRef Boulos PB, Botha A, Hobsley M, Holton J, Oshowo AO, Tovey FI (2002) Possible absence of Helicobacter pylori in the early stages of duodenal ulceration. QJM 95:749–752PubMedCrossRef
12.
go back to reference Dres Pest P, Zárate J, Varsky C, Man F, Schraier M (1996) Helicobacter pylori in recently-diagnosed versus chronic duodenal ulcer. Acta Gastroenterol Latinoam 26:273–276 Dres Pest P, Zárate J, Varsky C, Man F, Schraier M (1996) Helicobacter pylori in recently-diagnosed versus chronic duodenal ulcer. Acta Gastroenterol Latinoam 26:273–276
13.
go back to reference Hobsley M, Tovey FI (2001) Helicobacter pylori: the primary cause of duodenal ulceration or a secondary infection. World J Gastroenterol 7(2):149–151PubMed Hobsley M, Tovey FI (2001) Helicobacter pylori: the primary cause of duodenal ulceration or a secondary infection. World J Gastroenterol 7(2):149–151PubMed
14.
go back to reference Nath G, Khanna AK, Jain AK, Gulati VK (2000) Helicobacter pylori does not cause gastric carcinoma in India. Nat Med J India 13(6):328–329 Nath G, Khanna AK, Jain AK, Gulati VK (2000) Helicobacter pylori does not cause gastric carcinoma in India. Nat Med J India 13(6):328–329
15.
go back to reference Ally R, Mitchell HM, Segal I (2000) Differences in the immune response to H. pylori infection in Sowetan subjects may relate to concurrent parasitic infections. S Afr Med J 90:642 Ally R, Mitchell HM, Segal I (2000) Differences in the immune response to H. pylori infection in Sowetan subjects may relate to concurrent parasitic infections. S Afr Med J 90:642
16.
go back to reference Fox JG, Beck P, Dangler CA et al (2000) Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy. Nat Med 6(5):536–542PubMedCrossRef Fox JG, Beck P, Dangler CA et al (2000) Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy. Nat Med 6(5):536–542PubMedCrossRef
17.
go back to reference Rastogi T, Devesa S, Mangtani P et al (2008) Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int J Epidemiol 37(1):147–160PubMedCrossRef Rastogi T, Devesa S, Mangtani P et al (2008) Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int J Epidemiol 37(1):147–160PubMedCrossRef
18.
go back to reference Schmidt HM, Goh KL, Fock KM et al (2009) Distinct cagA EPIYA motifs are associated with ethnic diversity in Malaysia and Singapore. Helicobacter 14(4):256–263PubMedCrossRef Schmidt HM, Goh KL, Fock KM et al (2009) Distinct cagA EPIYA motifs are associated with ethnic diversity in Malaysia and Singapore. Helicobacter 14(4):256–263PubMedCrossRef
19.
go back to reference Mishra S, Singh V, Rao GR, Dixit VK, Gulati AK, Nath G (2008) Prevalence of Helicobacter pylori in asymptomatic subjects—a nested PCR based study. Infect Genet Evol 8:815–819PubMedCrossRef Mishra S, Singh V, Rao GR, Dixit VK, Gulati AK, Nath G (2008) Prevalence of Helicobacter pylori in asymptomatic subjects—a nested PCR based study. Infect Genet Evol 8:815–819PubMedCrossRef
20.
go back to reference Elitsur Y, Neace C, Werthammer MC, Triest WE (1999) Prevalence of CagA, VacA antibodies in symptomatic and asymptomatic children with Helicobacter pylori infection. Helicobacter 4(2):100–105PubMedCrossRef Elitsur Y, Neace C, Werthammer MC, Triest WE (1999) Prevalence of CagA, VacA antibodies in symptomatic and asymptomatic children with Helicobacter pylori infection. Helicobacter 4(2):100–105PubMedCrossRef
21.
go back to reference Carroll IM, Khan AA, Ahmed N (2004) Revisiting the pestilence of Helicobacter pylori: insights into geographical genomics and pathogen evolution. Infect Genet Evol 4:81–90PubMedCrossRef Carroll IM, Khan AA, Ahmed N (2004) Revisiting the pestilence of Helicobacter pylori: insights into geographical genomics and pathogen evolution. Infect Genet Evol 4:81–90PubMedCrossRef
22.
go back to reference Atherton JC, Blaser MJ (2009) Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 119:2475–2487PubMedCrossRef Atherton JC, Blaser MJ (2009) Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 119:2475–2487PubMedCrossRef
23.
go back to reference Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911–920PubMedCrossRef Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911–920PubMedCrossRef
24.
go back to reference Richter JE, Falk GW, Vaezi MF (1999) Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol 93:1800–1802CrossRef Richter JE, Falk GW, Vaezi MF (1999) Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol 93:1800–1802CrossRef
25.
go back to reference Rothenbacher D, Blaser MJ, Bode G, Brenner H (2000) Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study. J Infect Dis 182:1446–1449PubMedCrossRef Rothenbacher D, Blaser MJ, Bode G, Brenner H (2000) Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study. J Infect Dis 182:1446–1449PubMedCrossRef
26.
go back to reference Befrits R, Sjöstedt S, Ödman B, Sörngård H, Lindberg G (2000) Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease. Helicobacter 5(4):202–205PubMedCrossRef Befrits R, Sjöstedt S, Ödman B, Sörngård H, Lindberg G (2000) Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease. Helicobacter 5(4):202–205PubMedCrossRef
27.
go back to reference El-Omar EM, Oien K, El-Nujumi A et al (1997) Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113(1):15–24PubMedCrossRef El-Omar EM, Oien K, El-Nujumi A et al (1997) Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113(1):15–24PubMedCrossRef
28.
go back to reference Chow WH, Blaser MJ, Blot WJ et al (1998) An Inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 58:588–590PubMed Chow WH, Blaser MJ, Blot WJ et al (1998) An Inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 58:588–590PubMed
29.
go back to reference Williamson WA, Ellis FH Jr, Gibb SP et al (1991) Barrett’s esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 151:2212–2216PubMedCrossRef Williamson WA, Ellis FH Jr, Gibb SP et al (1991) Barrett’s esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 151:2212–2216PubMedCrossRef
30.
go back to reference Iftikhar SY, James PD, Steele RJC, Hardcastle JD, Atkinson M (1992) Length of Barrett’s oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 33:1155–1158PubMedCrossRef Iftikhar SY, James PD, Steele RJC, Hardcastle JD, Atkinson M (1992) Length of Barrett’s oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 33:1155–1158PubMedCrossRef
31.
go back to reference van Sandick JW, van Lanschot JJB, Kuiken BW, Tytgat GNJ, Offerhaus GJA, Obertop H (1998) Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma. Gut 43:216–222PubMedCrossRef van Sandick JW, van Lanschot JJB, Kuiken BW, Tytgat GNJ, Offerhaus GJA, Obertop H (1998) Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma. Gut 43:216–222PubMedCrossRef
Metadata
Title
Is Helicobacter pylori good or bad?
Author
S. Mishra
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2013
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1773-9

Other articles of this Issue 3/2013

European Journal of Clinical Microbiology & Infectious Diseases 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine